Know What's Happening in Healthcare

Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer

The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.

What New Atopic Dermatitis Treatments Are in the Pipeline in 2026?
NewsApr 21, 2026

What New Atopic Dermatitis Treatments Are in the Pipeline in 2026?

The atopic dermatitis pipeline in 2026 is dominated by next‑generation biologics and selective small molecules that aim to improve efficacy while reducing side‑effects. Connect Biopharma’s rademikibart achieved near‑complete skin clearance in a phase 3 trial, and Apogee’s extended‑half‑life zumilokibart showed durable...

By Labiotech.eu
The AI Drug Discovery Capital Stack in 2026: Who Has Raised the Most, Why Their Technical Approaches Actually Differ, and...
BlogApr 21, 2026

The AI Drug Discovery Capital Stack in 2026: Who Has Raised the Most, Why Their Technical Approaches Actually Differ, and...

The essay maps AI‑driven drug‑discovery firms’ capital stacks as of April 2026, highlighting that Eikon, Xaira, Isomorphic Labs and Recursion sit at the top of disclosed funding. It separates the sector into four technical lanes—structure foundation models, generative chemistry, phenomics/perturbational biology,...

By Thoughts on Healthcare Markets & Tech
Peer Supervision: A Model for Enhanced Vocational and Emotional Support
NewsApr 21, 2026

Peer Supervision: A Model for Enhanced Vocational and Emotional Support

A New York community health agency launched a Peer Supervision and Support Work Group to address rising instability among its peer workforce, including housing loss and substance‑use relapse. The initiative introduced three core programs—Enhanced Orientation, Life Skills Group, and Vocational...

By Behavioral Health News
Peering In: A Look at Mental Health Peer Providers and How They Help People Recover
NewsApr 21, 2026

Peering In: A Look at Mental Health Peer Providers and How They Help People Recover

Emily Grossman, a recovered bipolar II patient, became a certified peer specialist after traditional routes proved too costly. She now works in community mental health centers and runs her own practice, training clinicians on recovery‑oriented, person‑centered care. The article argues...

By Behavioral Health News
Addiction Recovery: The Role of Peer and Alumni Support
NewsApr 21, 2026

Addiction Recovery: The Role of Peer and Alumni Support

Addiction treatment programs are increasingly adding peer‑support and alumni networks to smooth the high‑risk transition from residential care to everyday life. Peer support delivers nonclinical, lived‑experience guidance, while alumni groups offer structured check‑ins, social reinforcement, and resource navigation. Evidence shows...

By Behavioral Health News
How Psychiatric Office Support Directly Improves Mental Health Treatment Outcomes
NewsApr 21, 2026

How Psychiatric Office Support Directly Improves Mental Health Treatment Outcomes

Serenity Mental Health Centers highlights how patient‑centered psychiatric care—anchored by robust office support—directly lifts treatment outcomes. By assigning each patient a team of seven or more staff, from care coordinators to psychiatrists, the clinic creates a strong therapeutic alliance that...

By Behavioral Health News
Strengthening Peer Services Through Partnership
NewsApr 21, 2026

Strengthening Peer Services Through Partnership

The peer‑delivered workforce in behavioral health has surged, with more than 100,000 individuals now certified as peer providers, according to a 2024 Peer Recovery Center of Excellence report. Peer professionals are now embedded across crisis services, hospitals, outpatient programs, housing...

By Behavioral Health News
Integrating Peers in CCBHCs: The Power of Lived Experience
NewsApr 21, 2026

Integrating Peers in CCBHCs: The Power of Lived Experience

Certified Community Behavioral Health Clinics (CCBHCs) are expanding a person‑centered model that bundles mental health, substance‑use treatment, case management, and physical health services. Peer Navigators and Peer Specialists are being woven into these multidisciplinary teams to bring lived‑experience insight and...

By Behavioral Health News
From Access to Engagement: Reimagining the Consumer Experience in Behavioral Health
NewsApr 21, 2026

From Access to Engagement: Reimagining the Consumer Experience in Behavioral Health

Behavioral health providers have expanded access through telehealth, portals, and peer services, yet consumer engagement remains weak. Recent surveys of providers and patients reveal that cumbersome intake processes and limited post‑visit interaction cause drop‑off during the critical early weeks of...

By Behavioral Health News
Quadricuspid Aortic Valve: The Diagnosis Hiding in Your Short-Axis View
BlogApr 21, 2026

Quadricuspid Aortic Valve: The Diagnosis Hiding in Your Short-Axis View

The article highlights the quadricuspid aortic valve, a rare congenital anomaly often mistaken for a bicuspid valve. Because sonographers rarely look for four cusps, the condition is mislabelled, allowing aortic regurgitation to progress unchecked. By focusing on the short‑axis echocardiographic...

By The Echo Journal
Inflammation, Not Cholesterol, Fuels Heart Disease
SocialApr 21, 2026

Inflammation, Not Cholesterol, Fuels Heart Disease

As a medical school professor, I have been saying this for years. Now Scientific American put it on the cover. "Your Heart In Flames" -- May 2026 issue. The argument: chronic inflammation, not cholesterol alone, is the real driver of cardiovascular disease. Up...

By Robert Lufkin, MD
Pharma Exporters Facing Issues with Online National Drug Licensing System
NewsApr 21, 2026

Pharma Exporters Facing Issues with Online National Drug Licensing System

Indian pharmaceutical exporters are encountering technical problems with the Online National Drug Licensing System (ONDLS), which issues Certificates of Pharmaceutical Products (COPP) under the WHO Good Manufacturing Practices scheme. The Pharmaceuticals Export Promotion Council (Pharmexcil) has launched a feedback drive...

By The Hindu BusinessLine – Companies
They Called Me a “Maverick”
BlogApr 21, 2026

They Called Me a “Maverick”

Dr. Gator, author of "Between a Shot and Hard Place," was profiled in The MAHA Report, where his stance on vaccine informed consent was examined. The article explores the widening gap between parents and the medical community, emphasizing the need...

By Dr. Gator - Between a Shot and Hard Place
Labor to Tackle Two of Budget’s Biggest Headaches – Aged Care and NDIS – in One Go
NewsApr 21, 2026

Labor to Tackle Two of Budget’s Biggest Headaches – Aged Care and NDIS – in One Go

Health Minister Mark Butler will announce a $1 bn AUD (≈$660 m USD) boost to aged‑care home‑care packages, fully funding showering, dressing and continence services for about 350,000 seniors. The same pre‑budget speech will unveil a sweeping overhaul of the $50 bn AUD...

By The Age – Books (Australia)
Biocon Receives Health Canada Approval for Bosaya and Vevzuo (Biosimilars, Prolia and Xgeva)
NewsApr 21, 2026

Biocon Receives Health Canada Approval for Bosaya and Vevzuo (Biosimilars, Prolia and Xgeva)

Biocon has secured a Notice of Compliance from Health Canada for its denosumab biosimilars, Bosaya and Vevzuo, which mirror Amgen’s Prolia and Xgeva. The approval follows a comprehensive data package demonstrating comparable quality, safety and efficacy to the reference products....

By PharmaShots
Self‑Experiment Shows High‑Dose Statins May Reduce Exercise Performance
SocialApr 21, 2026

Self‑Experiment Shows High‑Dose Statins May Reduce Exercise Performance

1/2) Given emerging literature I decided to test, in a randomized, placebo-controlled crossover experiment conducted on myself whether high-dose statins would impair my exercise performance.

By Nick Norwitz MD PhD
EMI Filter for High-Field MRI Systems and Sensitive Imaging Processes From EMIS
NewsApr 21, 2026

EMI Filter for High-Field MRI Systems and Sensitive Imaging Processes From EMIS

EMIS has launched the MF420-2CF-M MRI filter, a specialized EMI/RFI filter for high‑field MRI suites. The filter delivers attenuation up to 10 GHz, protecting power and data lines entering shielded rooms. Its design features threaded conduit connections, a discharge bleeder resistor,...

By Microwave Journal
Please Don’t Trust Your Chatbot for Medical Advice
BlogApr 21, 2026

Please Don’t Trust Your Chatbot for Medical Advice

Recent peer‑reviewed studies across BMJ, JAMA Network Open, and Nature Medicine reveal that popular AI chatbots—including ChatGPT, Gemini, and Meta AI—frequently generate inaccurate, hallucinated, or overconfident medical advice. The BMJ audit found nearly half of responses were highly problematic, while...

By Marcus on AI
Patients Seek Google First, Doctors Become Last Resort
SocialApr 21, 2026

Patients Seek Google First, Doctors Become Last Resort

A mother once came to me with her 8 year old. First thing she said wasn't the symptoms. It was "Doctor, I read online that it could be... She had already diagnosed her child. Already half-decided the treatment. She just needed me...

By Vishal Sengar, MD
MyChart’s 250 Deep Links Reveal Limits of Data‑Only Portals
SocialApr 21, 2026

MyChart’s 250 Deep Links Reveal Limits of Data‑Only Portals

Everyone has strong opinions about MyChart. I decided to stop speculating and take a look under the hood. The MyChart APK declares roughly 250 deep links covering everything from geofenced appointment check-in to payer-to-payer data exchange to bedside tablet pairing. The...

By Brendan Keeler
How to Speed Up Your Root Canal Recovery
NewsApr 21, 2026

How to Speed Up Your Root Canal Recovery

Root canal treatments succeed in over 95% of cases, but recovery experiences vary widely. The healing process unfolds in three phases—immediate (24‑48 hours), intermediate (days 3‑7), and final (weeks 2‑4)—each with distinct symptoms and care needs. Effective pain control with ibuprofen, ice, and...

By Healthcare Guys
This Biotech Firm Has Room to Run Despite Surging Nearly 500% in Past Year, Morgan Stanley Says
NewsApr 21, 2026

This Biotech Firm Has Room to Run Despite Surging Nearly 500% in Past Year, Morgan Stanley Says

Arrowhead Pharmaceuticals’ stock has rocketed 473% over the past year, prompting Morgan Stanley to upgrade the shares to overweight and lift its price target to $100 from $78, indicating roughly a 44% upside. The firm is set to release Phase‑3...

By CNBC – ETFs
Unmet Needs and Key Takeaways for Community Oncologists
NewsApr 21, 2026

Unmet Needs and Key Takeaways for Community Oncologists

Community oncologists face unresolved questions in prostate cancer treatment, especially the optimal sequencing of chemotherapy with androgen‑receptor pathway inhibitors (ARPIs) added to ADT. Existing trials such as ARCHES and PEACE‑1 were designed around ARPI‑plus‑docetaxel, leaving uncertainty about the benefit of...

By AJMC (The American Journal of Managed Care)
Advancing in Modern Healthcare: Why DNP Education Is Gaining Attention
NewsApr 21, 2026

Advancing in Modern Healthcare: Why DNP Education Is Gaining Attention

Advanced nursing education, especially Doctor of Nursing Practice (DNP) programs, is gaining momentum as health systems adopt digital tools and data‑driven care. Enrollment in DNP programs has risen sharply, reflecting demand for leaders who can translate research into practice. Flexible...

By Health Tech Digital (UK)
Medicare: CMS’s Use of Data Analytics to Identify and Prevent Fraud
NewsApr 21, 2026

Medicare: CMS’s Use of Data Analytics to Identify and Prevent Fraud

The Centers for Medicare & Medicaid Services (CMS) is leveraging data analytics to detect and stop Medicare fraud, focusing on anomalous billing patterns and spikes. Using these tools, CMS suspended payments and revoked enrollment for 15 providers tied to a...

By GAO – Health Care
Peer Support Boosts Reproductive Agency Where Vouchers Fall Short
NewsApr 21, 2026

Peer Support Boosts Reproductive Agency Where Vouchers Fall Short

In rural Uttar Pradesh, a randomized trial of 671 married women compared a personal family‑planning voucher with a “Bring‑a‑Friend” (BAF) voucher that also offered peer support. Both vouchers increased clinic visits, but only the BAF design raised modern contraceptive use...

By VoxDev
Selecting Patients for Immunotherapy in CSCC: Key Considerations
NewsApr 21, 2026

Selecting Patients for Immunotherapy in CSCC: Key Considerations

Cutaneous squamous cell carcinoma (CSCC) treatment is shifting toward earlier use of systemic immunotherapy, especially for moderate‑risk tumors that are still resectable. Dr. Vishal Patel of George Washington Cancer Center urges clinicians to evaluate checkpoint inhibitors alongside surgery, guided by...

By AJMC (The American Journal of Managed Care)
PSMA PET and the Evolving Imaging Landscape in Prostate Cancer
NewsApr 21, 2026

PSMA PET and the Evolving Imaging Landscape in Prostate Cancer

In the 2026 prostate cancer guidelines, PSMA‑PET is elevated to an indispensable imaging tool, expanding beyond initial staging of unfavorable intermediate‑risk and higher‑risk disease to cover biochemical recurrence, including second recurrences. The modality now informs decisions on oligometastatic identification for...

By AJMC (The American Journal of Managed Care)
Rethinking When to Start Long-Acting HIV Therapy
NewsApr 21, 2026

Rethinking When to Start Long-Acting HIV Therapy

Real‑world data from the OPERA cohort of over 5,000 patients show that starting long‑acting cabotegravir plus rilpivirine (CAB+RPV LA) in individuals with detectable viral loads—about 11% above 50 copies/mL—can still achieve virologic suppression comparable to patients who begin treatment already...

By AJMC (The American Journal of Managed Care)
The Future of Psoriasis Management: Integration, Innovation, and Holistic Care
NewsApr 21, 2026

The Future of Psoriasis Management: Integration, Innovation, and Holistic Care

Psoriasis management has shifted from modest skin improvement to aiming for complete clearance, driven by a growing arsenal of topicals, biologics, and emerging oral IL‑23 inhibitors. Real‑world data from the Winter Clinical Hawaii 2026 conference show higher persistence with biologics among...

By AJMC (The American Journal of Managed Care)
MyChart Unpacked
BlogApr 21, 2026

MyChart Unpacked

The author performed a static inspection of Epic’s MyChart Android application package, uncovering roughly 250 custom deep‑link URLs that route users directly to specific screens. By decompiling the APK, the analysis reveals a richer feature set than the typical web‑based...

By Health API Guy
Dr-Julian to Provide Online Mental Health Platform for North East and North Cumbria
NewsApr 21, 2026

Dr-Julian to Provide Online Mental Health Platform for North East and North Cumbria

Dr-Julian has secured funding from the NHS North East and North Cumbria Integrated Care Board to launch a 24/7 online mental health platform. The initiative is part of the region’s £19 million (≈$24 million) WorkWell programme aimed at reducing unemployment caused by...

By Health Tech Digital (UK)
Monopar Therapeutics Reports P-III (FoCus) Trial Data on ALXN1840 in Wilson Disease
NewsApr 21, 2026

Monopar Therapeutics Reports P-III (FoCus) Trial Data on ALXN1840 in Wilson Disease

Monopar Therapeutics reported Phase III FoCus trial results for ALXN1840, an oral copper‑binding agent, in Wilson disease patients with neurologic involvement. The study enrolled 77 patients on ALXN1840 and 35 on standard of care, showing neurologic worsening in only 9% versus...

By PharmaShots
The Hidden Cost of IV Fluid Shortages on Outpatient Facilities: What the Data Shows
NewsApr 21, 2026

The Hidden Cost of IV Fluid Shortages on Outpatient Facilities: What the Data Shows

The 2024‑2025 IV fluid shortage, sparked by Hurricane Helene’s damage to Baxter’s North Cove plant, has spilled over from hospitals to thousands of outpatient facilities such as infusion centers, ambulatory surgery centers, pain clinics, and oncology practices. While hospitals can...

By Healthcare Guys
Metabolic Health Drives Knee Osteoarthritis Progression
SocialApr 21, 2026

Metabolic Health Drives Knee Osteoarthritis Progression

Knee Osteoarthritis Thread 4: Metabolic Health and the Knee. Your metabolic health will directly impact how your knee feels more than you can imagine. Your metabolic health directly influences how quickly your arthritis progresses and how your cartilage responds to...

By Howard Luks, MD
Regulatory Hurdles, Not Tech, Slow Biotech Breakthroughs
SocialApr 21, 2026

Regulatory Hurdles, Not Tech, Slow Biotech Breakthroughs

"We need 6 'AlphaFold' moments to compress the drug delivery timeline from 10yrs to a few months" -Demis Yes and the FDA will still take 10yrs to approve it. Safetyism has throttled biotech unnecessarily and the only way to accelerate is to...

By Ryan Bethencourt
The Reality of PrEP Access and HIV Prevention in Georgia
BlogApr 21, 2026

The Reality of PrEP Access and HIV Prevention in Georgia

Georgia holds the nation’s second‑highest rate of new HIV diagnoses, prompting lawmakers to pass a bill that authorizes pharmacists to prescribe PrEP without a physician visit. While the measure could streamline access, the article highlights that half a million Georgians...

By KevinMD
Nicotinamide Riboside Blocks Lasting Mitochondrial Damage Post‑asphyxia
SocialApr 21, 2026

Nicotinamide Riboside Blocks Lasting Mitochondrial Damage Post‑asphyxia

Long-term region-specific mitochondrial respiration impairment after perinatal asphyxia is prevented by the NAD⁺ donor nicotinamide riboside: A real-time organotypic metabolic profiling approach https://t.co/ZGyAxcnNAC https://t.co/w0VJkAmlHT

By David Barzilai, MD PhD
UnitedHealth's Profit Strategy: Deny Patients Needed Medication
SocialApr 21, 2026

UnitedHealth's Profit Strategy: Deny Patients Needed Medication

UnitedHealth just told Wall Street their plan for more profits is to deny more medicine to people. https://t.co/JYysdCAPBw

By Matt Stoller
Patients Stay Cancer-Free Three Years After Clinical Trial
BlogApr 21, 2026

Patients Stay Cancer-Free Three Years After Clinical Trial

A phase II trial at UCL tested pembrolizumab as neoadjuvant therapy for 32 patients with stage II‑III MMR‑deficient/MSI‑high bowel cancer. After up to nine weeks of immunotherapy before surgery, 59% showed no detectable tumor and none experienced recurrence over a median...

By Health Tech World
Tortugas Neuroscience Launches to Develop Brain Disorder Drugs
SocialApr 21, 2026

Tortugas Neuroscience Launches to Develop Brain Disorder Drugs

Tortugas Neuroscience launches with hopes to develop drugs for brain disorders, other conditions https://t.co/zoM69VEQtV via @ADeAngelis_bio

By Adam Feuerstein
Trump Order Boosts Psychedelic Biotech Stocks
SocialApr 21, 2026

Trump Order Boosts Psychedelic Biotech Stocks

Trump executive order lifts psychedelics biotechs https://t.co/3H00cxuF4A by @realJacobBell $GHRS $HRELP $DFTX $ENVB $COMP $ATAI #biotech

By Ben Fidler
STAT+: Tortugas Neuroscience Launches with Hopes to Develop Drugs for Brain Disorders, Other Conditions
NewsApr 21, 2026

STAT+: Tortugas Neuroscience Launches with Hopes to Develop Drugs for Brain Disorders, Other Conditions

Tortugas Neuroscience launched with a $106 million financing round led by Cure Ventures, The Column Group and AN Ventures. The startup has licensed two schizophrenia and tinnitus candidates from China’s Jiangsu Hansoh and two additional therapies for focal epilepsy and encephalopathies...

By STAT (Biotech)
Fluoride In Drinking Water Not Linked to Lower IQ
NewsApr 21, 2026

Fluoride In Drinking Water Not Linked to Lower IQ

A new longitudinal study of 10,317 Wisconsinites spanning 1957‑2021 found no link between community water fluoridation and lower IQ or cognitive decline. The research directly challenges a 2025 paper that reported IQ reductions at fluoride concentrations far exceeding typical U.S....

By Womens Health
Serif Targets Revolutionary Genetic Medicine Platform
SocialApr 21, 2026

Serif Targets Revolutionary Genetic Medicine Platform

Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine https://t.co/kvmbF3xYKu by @gwendolynawu #biotech #startups @FlagshipPioneer

By Ben Fidler
Twin Study Links Childhood Trauma to Higher Risk of Treatment‑Resistant Depression
NewsApr 21, 2026

Twin Study Links Childhood Trauma to Higher Risk of Treatment‑Resistant Depression

A new twin study from the Karolinska Institute shows that adverse childhood experiences significantly increase the likelihood of treatment‑resistant depression, with five percent of those reporting three or more traumas developing the condition versus 0.7 percent of trauma‑free peers. The...

By Pulse
“Cancer Isn’t Political, It’s Personal”: A Funding Update From the 2026 AACR Annual Meeting
BlogApr 21, 2026

“Cancer Isn’t Political, It’s Personal”: A Funding Update From the 2026 AACR Annual Meeting

At the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, scientists displayed “Thank you, Congress” signs after lawmakers blocked a proposed 40% cut to NIH funding. A policy town‑hall highlighted how the 2025 funding uncertainty delayed trials,...

By BioTechniques (independent journal site)
UF/IFAS Study Finds Simple Diet Tweaks Yield Major Health Gains
NewsApr 21, 2026

UF/IFAS Study Finds Simple Diet Tweaks Yield Major Health Gains

University of Florida’s Institute of Food and Agricultural Sciences released a study showing that modest, consistent changes to diet—more fiber, anti‑inflammatory foods and better eating timing—can dramatically improve cholesterol, reduce abdominal fat and extend life expectancy, even for adults over...

By Pulse
A Pivotal Year for Regulatory Reform and Innovation
BlogApr 21, 2026

A Pivotal Year for Regulatory Reform and Innovation

Britain’s Medicines & Healthcare products Regulatory Agency (MHRA) is advancing its MedTech regulatory reform, introducing a pre‑market statutory instrument that adds an international reliance scheme, updated classification, mandatory UDIs and stricter claim rules. The agency also plans an Early Access...

By Med-Tech Insights